DEMENTIA/ALZHEIMER

The founder and CEO of NeuroEM Therapeutics discussed the potential of transcranial electromagnetic treatment, or TEMT, in treating patients with Alzheimer disease, with the hope of reversing cognitive impairment.
Modern strategies used to inform the management of Alzheimer disease, particularly blood tests and the role of protofibrils, are considered.

SAP Partner Banner

About NeurologyLive's Dementia & Alzheimer Clinical Focus page:

NeurologyLive Dementia & Alzheimer Disease Clinical Focus page serves as a resource for clinical news, articles, videos, and newly released data pertaining to both dementia and Alzheimer disease. Coverage found here includes updates from the floor of conferences and annual meetings attended by the world’s most respected key neurology thought leaders, as well as video interviews with leading experts in these neurological disorders.

This page features breaking news coverage of approvals from the U.S. Food and Drug Administration (FDA), key takeaways from the new and emerging therapies being evaluated in clinical trials, and notifications of updates to clinical guidelines. The Dementia & Alzheimer Clinical Focus page provides relevant, high-quality resources for practicing neurologists, to help improve patient care.